Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott S Zamvil

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|February 10, 2025
<i>Neurology® Neuroimmunology and Neuroinflammation</i> Enters Its Second DecadeScott S Zamvil
Cold Spring Harbor Perspectives in Medicine|February 15, 2018
The Evolving Mechanisms of Action of Glatiramer AcetateThomas Prod'homme, Scott S Zamvil
Neurology(R) Neuroimmunology & Neuroinflammation|May 18, 2021
Can Systemic Anti-CD20 B Cell-Depleting Antibodies Eliminate Meningeal Follicles in Multiple Sclerosis?Sasha Gupta, Scott S Zamvil
Trends in Immunology|September 13, 2005
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosisLawrence Steinman, Scott S Zamvil
Neuron|June 12, 2003
Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosisScott S Zamvil, Lawrence Steinman
Annals of Neurology|June 28, 2006
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosisLawrence Steinman, Scott S Zamvil
Annals of Neurology|October 30, 2010
Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosisLawrence Steinman, Scott S Zamvil
Nature Medicine|June 7, 2008
Bench to bedside: tempering antigen-presenting cells in multiple sclerosisThomas Prod'homme, Scott S Zamvil
Cell|January 23, 2026
Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosisLawrence Steinman, Scott S Zamvil
Annals of Neurology|March 28, 2012
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis opticaLawrence Steinman, Scott S Zamvil
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Neurology(R) Neuroimmunology & Neuroinflammation|February 10, 2025
<i>Neurology® Neuroimmunology and Neuroinflammation</i> Enters Its Second DecadeScott S Zamvil
Cold Spring Harbor Perspectives in Medicine|February 15, 2018
The Evolving Mechanisms of Action of Glatiramer AcetateThomas Prod'homme, Scott S Zamvil
Neurology(R) Neuroimmunology & Neuroinflammation|May 18, 2021
Can Systemic Anti-CD20 B Cell-Depleting Antibodies Eliminate Meningeal Follicles in Multiple Sclerosis?Sasha Gupta, Scott S Zamvil
Trends in Immunology|September 13, 2005
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosisLawrence Steinman, Scott S Zamvil
Neuron|June 12, 2003
Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosisScott S Zamvil, Lawrence Steinman
Annals of Neurology|June 28, 2006
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosisLawrence Steinman, Scott S Zamvil
Annals of Neurology|October 30, 2010
Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosisLawrence Steinman, Scott S Zamvil
Nature Medicine|June 7, 2008
Bench to bedside: tempering antigen-presenting cells in multiple sclerosisThomas Prod'homme, Scott S Zamvil
Cell|January 23, 2026
Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosisLawrence Steinman, Scott S Zamvil
Annals of Neurology|March 28, 2012
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis opticaLawrence Steinman, Scott S Zamvil
Pageof 21